Dr Reddy's Lab launches Omeprazole in the US market
New Delhi: Dr Reddy's Laboratories recently said it has launched Omeprazole delayed-release tablets, used to treat frequent heartburn, in the US market.
"Dr Reddy's Laboratories has launched Omeprazole delayed-release tablets in the strength of 20 mg, an over-the-counter (OTC) store-brand equivalent of Prilosec tablets, in the US," the company said in a BSE filing.
Milan Kalawadia, Dr Reddy's Laboratories Vice President and Head, US OTC and Speciality Rx businesses said, this launch illustrates the company's continued commitment to the OTC business as well as the depth and breadth of its OTC portfolio.
Quoting IRI data, Dr Reddy's Laboratories said the combined market of Prilosec OTC and private label omeprazole OTC products had US retail sales of around USD 492 million for the most recent twelve months ending in October 2018.
Read Also: Dr Reddy’s Laboratories recalls 35,000 tubes of skin infection cream from US
Next Story
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd